Metabolic syndrome and cardiovascular risk
Charbonnel, B.
La Revue du Praticien 55(16): 1765-1771
2005
ISSN/ISBN: 0035-2640 PMID: 16363426 Document Number: 590095
Metabolic syndrome points out numerous vascular risk factors clustering together, due to a common mechanistic substratum, visceral obesity and insulin resistance. The definitions of the syndrome allow to identify individuals at risk of vascular disease and diabetes but actually do not add anything to the predictive value of the individual components of the syndrome. Metabolic syndrome could become a target for some specific therapeutic interventions.
Document emailed within 1 workday
Related Documents
Pan, C.-Y.; Cheng, Y. 2004: Metabolic syndrome: a high-cardiovascular risk Zhonghua Nei Ke Za Zhi 43(11): 801-802Fiuza, M.; Cortez-Dias, N.; Martins, S.; Belo, A.; Dias, A.D.C.; Neves, A.S.; Frazão, A.é; Pereira, A.ón.A.P.; Do Vale, A.ón.F.M.; Dias Simas, A.M.; Estrela, C.; Amorim, E.A.; Almeida, F.E.M.; Amaral, G.M.B.; Silva, I.M.S.; Sousa, J.M.M.; Morgado, J.M.O.; Santos, J.é C.O.; Senra, J.é F.M.; Amaral, L.G.M.; Aleixo, L.G.; Soares, L.M.S.; Cafede, M.C.F.A.; Colleo, M.O.M.C.; Senra, M.C.M.; Ramiro, M.J.R.C.C.; Borges, M.M.S.A.P.; Amaral, P.N.P.; Andrade, R.M.L.; Costa, R.P.D.R.C.; Conde, A.I.; Rodrigues, A.; Santana, A.; Morais, A.S.; Cardoso, A.A.M.V.; Barros, A.; Perez, A.; Matias, A.; Carina, A.; Cardoso, A.M.C.S.E.; Dinis, A.R.F.; Santana, A.; Baltazar, A.; Vieira, A.ón.J.é C.; Farias, A.M.; Martins, A.V.; Magalhães, A.M.B.; Graça,; 2008: Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 27(12): 1495-1529
Volf, E.M.; Levine, D.E.; Michelon, M.A.; Au, S.-C.; Patvardhan, E.; Dumont, N.; Loo, D.S.; Kuvin, J.; Gottlieb, A.B. 2011: Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts Journal of Drugs in Dermatology: Jdd 10(8): 900-901
Cheung, L.P.; Ma, R.C.W.; Lam, P.M.; Lok, I.H.; Haines, C.J.; So, W.Y.; Tong, P.C.Y.; Cockram, C.S.; Chow, C.C.; Goggins, W.B. 2008: Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome Human Reproduction 23(6): 1431-1438
Sánchez-Torres, R.J.; Delgado-Osorio, H.éc. 2005: The metabolic syndrome and its cardiovascular manifestations Boletin de la Asociacion Medica de Puerto Rico 97(4): 271-280
Vitarius, J.A. 2005: The metabolic syndrome and cardiovascular disease Mount Sinai Journal of Medicine new York 72(4): 257-262
Os, I.; Hjermann, I.; Nordby, G. 1991: Hypertension as a part of metabolic cardiovascular syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(25): 3062-3064
Zeman, M.; Zák, A.; Vecka, M.; Tvrzická, E. 2005: Insulin resistance, metabolic syndrome and cardiovascular diseases Casopis Lekaru Ceskych 144(Suppl 1): 19-20; 22-26
Bano, K.A.; Batool, A. 2007: Metabolic syndrome, cardiovascular disease and type-2 diabetes JPMA. Journal of the Pakistan Medical Association 57(10): 511-515
Guo, L.; Hu, X-shu.; Guo, Z-rong.; Kang, G-dong.; Wu, M.; Zhou, H. 2009: Association and interaction between the components of metabolic syndrome and cardiovascular disease Zhonghua Xin Xue Guan Bing Za Zhi 37(7): 644-647
Vuletić, S.; Kern, J.; Ivanković, D.; Polasek, O.; Brborović, O. 2007: Metabolic syndrome in the Croatian population--the multiple cardiovascular risks Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 61(3): 239-243
Kozłowska, A.; Kowalska, I. 2006: The role of adiponectin in pathogenesis of metabolic syndrome and cardiovascular disease Endokrynologia Polska 57(6): 626-632
Soares, G.M.; Vieira, C.S.; de Paula Martins, W.; Dos Reis, R.M.; de Sá, M.F.S.; Ferriani, R.A. 2009: Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome International Journal of Clinical Practice 63(1): 160-169
Ford, E.S. 2005: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28(7): 1769-1778
Bognounou, R.; Diendéré, A.; Diallo, I.; Tieno, H.; Guira, O.; Ouedraogo, D.D.; Drabo, Y.J. 2011: Metabolic disorders and cardiovascular risk factors observed in patients infected by the HIV with antiretroviral therapy in Burkina Faso Medecine Tropicale: Revue du Corps de Sante Colonial 71(6): 626-627
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667
Tsujii, S.; Kuzuya, H. 2004: The significance of lifestyle as a risk factor for the metabolic syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 62(6): 1047-1052
Molero-Conejo, E.; Morales, L.Marina.; Fernández, V.; Raleigh, X.; Gómez, M.Esther.; Semprún-Fereira, M.; Campos, G.; Ryder, E. 2003: Lean adolescents with increased risk for metabolic syndrome Archivos Latinoamericanos de Nutricion 53(1): 39-46
Lichiardopol, C.; Mota, M. 2004: Cardiovascular risk factors in Turner syndrome Romanian Journal of Internal Medicine 42(2): 371-379